化疗致血小板减少症临床治疗进展

Clinical Therapy Progress in Thrombocytopenia after Chemotherapy

化疗是治疗恶性肿瘤的重要手段之一,但化疗往往会导致严重的骨髓抑制,出现白细胞、血小板等血细胞下降,目前针对化疗后血小板减少的治疗主要包括输注人血小板、白介素-11(IL-11)、重组人血小板生成素(rhTPO)等,但价格昂贵且副作用较大,而中医药作为我国肿瘤治疗中的特色,在这一方面有明显优势,可保护骨髓造血功能,有效地提升血小板水平。

Chemotherapy is one of the most important therapies for patients with cancer. Chemotherapy will often cause severe marrow inhibition, leading to blood cells decrease such asleukemia, thrombocytopenia.Currently, treatments to thromboeytopenia after chemotherapy include infusion of human platelet, interleukin-11 （ IL-11 ）and recombinant human thrombopoietin （ rhTPO ）. But the price is high and has severe adverse reactions.Traditional Chinese medicine as the characteristic therapy in China, has obvious advantages.h can protects the hemopoietic function of marrow, and improve platelet effectively.